Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortAntibody that clears B-cells — for lymphoma and autoimmune disease.Chemotherapy that also treats severe autoimmune disease.
Body systemCancerCancer
Drug classTargeted antibodiesAlkylating agents
SupplyPrescription onlyWHO essential medicinePrescription onlyWHO essential medicine
Main usesNon-Hodgkin lymphoma, Chronic lymphocytic leukaemia, Rheumatoid arthritis, ANCA vasculitis, PemphigusLymphoma, Breast cancer, Leukaemia, Severe lupus and vasculitis, Before stem cell transplants
How it worksRemoves a type of immune cell involved in lymphoma and some autoimmune diseases.Damages DNA so dividing cells die.
Starts working——
Half-lifeAbout 3 weeks—
Typical adult doseLymphoma: 375 mg/m² per cycle. Rheumatoid arthritis: 1 g twice, 2 weeks apart.Varies widely by condition and regimen.
FormsIV infusion, Subcutaneous injectionIV infusion, Tablet
Common side effectsInfusion reactions (first dose), Infections, Low white cellsNausea, Hair loss, Low blood counts
Serious side effectsHepatitis B reactivation, PML (rare brain infection), Severe infusion reactionsBleeding from the bladder, Infertility, Secondary cancers, Infections
Don't take if——
Alcohol——
PregnancyUsually avoidedContraception for 12 months after.Usually avoidedCauses birth defects.
Breastfeeding——
In use since19971959
Brand namesUnited States: Rituxan, Truxima, RuxienceUnited Kingdom: MabThera, Truxima, RixathonIndia: Reditux, MabtasUnited States: Cytoxan (historic)United Kingdom: CyclophosphamideIndia: Endoxan, Cyclomide
Legal status——
ATC codeL01FA01L01AA01

Taken together

No interaction between these medicines is recorded in the atlas.

Open in the interaction checker